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Clinical factors that affect blood gases in 
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Department of Medicine [II), Niigata University School of Medicine, Niigafa 951, Japan 
Chronic liver disease is often accompanied by hypoxaemia. We investigated the clinical factors that were related to 
the arterial oxygen tension (PaO,) in 40 women, all non-smokers with chronic liver disease. They were positive for 
hepatitis C virus (HCV) antibody and had no evidence of cardiopulmonary disease. Arterial blood was collected 
from patients at rest (> 15 min) for analysis of blood gases. We determined the correlation between blood gas tension 
and the clinical variables, i.e. the presence or absence of skin manifestations such as cutaneous spider nevi and 
palmar erythema, the presence or absence of splenomegaly, vital capacity, forced expiratory volume in one second, 
t;,/body height, serum alanine aminotransferase (AST), serum asparate aminotransferase (ALT), serum cholineste- 
rase, serum y-globulin/total protein, excretion of indocyanine green at 15 min (15-min retention rate, ICG level), 
blood level of ammonia, blood level of endotoxin, plasma level of glucagon and the serum level of type IV 
collagen-7s. The mean level of PaO, was 78 * 11 (range: 43-95) torr. The mean alveolar-arterial oxygen tension 
gradient (A-aDO,) was 19 rt 13 (range: 2-60) torr. Multiple regression analysis used PaO, and A-&O, as objective 
variables, and the clinical findings as explanatory variables. The explanatory variables that were significantly 
correlated with blood gas values were ICG level, blood level of endotoxin and presence of skin manifestations. The 
ICG level showed a high correlation with blood gas values; the ICG level increased, the PaO, decreased (r= - 0.69), 
while the A-aD0, showed a high positive correlation (r=+0.78, P<O.OOl). Findings suggest that a reduction in 
hepatic blood flow and hepatocellular function interfere with the inactivation of vasoactive substances such as 
endotoxin by the liver, leading to the development of skin manifestations, the dilatation of intrapulmonary 
capillaries and the induction of hypoxaemia. 
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Introduction 
It has been reported that skin manifestations such as 
cutaneous spider nevi and palmar erythema, the levels of 
vasoactive substances (endotoxin, glucagon) in peripheral 
blood, may all be related to the hypoxaemia observed 
in patients with chronic liver disease (l-6). Thus, the 
identification of certain clinical signs and symptoms 
may be predictive of hypoxaemia. While the relation- 
ship between hypoxaemia and clinical factors has been 
described (l-3,7-16), few studies of predictive factors 
have been performed using multivariate analysis. The 
present study was conducted in non-smokers with 
chronic liver disease to investigate, by multivariate 
analysis, the clinical factors that were associated with 
hypoxaemia. 
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Methods 
SUBJECTS 
Forty Japanese women with chronic liver disease (age range 
33-81 years; mean 69 + 12 years) who were positive for 
antibody to hepatitis C virus (HCV) were admitted to the 
study. Informed consent was obtained from each subject 
before the initiation of the study, which had been approved 
by the authors’ institute’s Committee on Clinical Research. 
None had a history of smoking, evidence of cardio- 
pulmonary disease, a history of gastrointestinal bleeding or 
a history of hepatocellular carcinoma. AI1 patients were 
categorized in Class A (N=36) and Class B (N=4) of the 
Child-Pugh classification. This system reflects the status of 
the patient’s liver function, which is classified as A, B or C 
according to an evaluation of ascites (absent in Class A, 
and slight to moderate in Class B); encephalopathy (absent 
in Class A, and Grades I-II in Class B); serum albumin 
level (13.5 g dl- ’ in Class A, and 3.0-3.5 g dl- i in Class 
B); serum bilirubin level (~2.0 mg dl - ’ in Class A, and 
2.0-3.0 mg dl- ’ in Class B); and prothrombin time (~4.0 s 
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longer than the control in Class A, and 4+6.0 s longer 
than the control in Class B) (17). Liver biopsy in 10 patients 
confirmed the diagnosis of liver cirrhosis. The mean serum 
level of asparate aminotransferase (AST) was 64 i 31 
(range: 26-160, normal: 10-27) IU l-i, that of alanine 
aminotransferase (ALT) was 55 + 31 (range: 14146, 
normal: 5-33) IU l- ‘, and that of cholinesterase (Ch-E) 
was 229 f 89 (range: 82429, normal: 300-720) IU 1 - ‘. 
BLOOD GAS ANALYSIS 
After the patient had rested supine for at least 15 min, 
blood was drawn from the brachial artery into heparinized 
tubes with the patient remaining supine. The pH was 
determined with an automatic pH blood gas analyser (Ciba 
Corning 278, Ciba-Corning-Diagnostic Corp, Tokyo, 
Japan), with the simultaneous measurement of arterial 
oxygen tension (PaO,) and arterial carbon dioxide tension 
(PaCO,). The ideal alveolar oxygen tension (PA02) was 
calculated from the PaCO, according to the method of 
Comroe as follows (18): 
P,O,= {P ,O, - PaCO,/R+ [F,O, X PaCO, X (l-R)IR}, 
where Fro, is the fractional concentration of oxygen in the 
inspired air and R is the respiratory exchange ratio. We 
used a R value of 0.8. Using the gradient of PA02 and 
PaO,, we calculated the alveolar-arterial oxygen tension 
gradient (A-aDO,=P,oZ - PaO,). 
CLINICAL FACTORS 
The following clinical variables were evaluated within 
1 week of blood gas analysis as possible factors involved in 
hypoxaemia: age; presence or absence of skin manifesta- 
tions such as cutaneous spider nevi and palmar erythema; 
the presence or absence of splenomegaly; vital capacity 
(% VC, % predicted value); forced expiratory volume in one 
second (FEV, %); t;,lbody height (l&/Ht); serum AST; 
serum ALT; serum Ch-E; serum y-globulin/serum total 
protein (y-glltotal protein, normal: 8.9-20.3 %); level of 
indocyanine green (ICG) excretion at 15 min (15-min 
retention rate, ICG level, normal: O-10 %); blood level of 
ammonia (normal: 19-82pg dl - ‘); blood level of endo- 
toxin (normal: O-10 pg mll I); plasma level of glucagon 
(normal: 70-160 pg ml - I); and serum level of type IV 
collagen-7S (normal: O-6 ng ml ~ ‘). 
Respiratory function was determined with a hot-wire 
flowmeter (Autospiro AS-7, Minato Corp., Tokyo, Japan). 
The % VC was predicted using an equation of Cotes et al. 
(19). FEV, % was calculated by the method of Gaensler 
et al. (20). 
The ICG excretion test was performed as follows (21,22). 
The serum level of ICC was measured in the morning after 
an overnight fast. A 3 ml blood sample was obtained, 
followed by the intravenous injection of ICG, 0.5 mg per kg 
of body weight into the brachial vein. In exactly 15 min, a 
3 ml blood sample was collected from another brachial 
vein. Samples were centrifuged at 3000 rpm for 10 min and 
the separated sera were analysed by spectrophotometry at 
805 nm. Serum ICG concentrations were plotted against 
time on a semi-logarithmic scale. The concentration at zero 
time of ICG was calculated from the exponential curves. 
The ICG level was calculated from the following formula: 
ICC level (%)= 15 min concentration of ICC/zero time 
concentration of ICG x 100. 
The blood ammonia level was determined by an enzy- 
matic method (Monotest ammonia, Boehringer Mannheim 
Corp., Tokyo, Japan). The blood level of endotoxin was 
determined by the toxicolour method (a colourimetric 
limulus test) (23). The plasma level of glucagon and the 
serum level of type IV collagen-7S were each measured 
by radioimmunoassay (Biomedical Laboratories Corp., 
Tokyo, Japan). The presence of splenomegaly (220 cm”) 
was evaluated by abdominal echography (Aloka SSD- 650, 
Aloka, Tokyo, Japan). The size of the patient’s spleen was 
determined from the following formula: 
Spleen size=diameter between the hilum and the anterior 
extremity of the spleen x its vertical diameter. 
STATISTICAL ANALYSIS 
Results are expressed as the mean * standard deviation and 
the range. The relationship between PaO,, A-aD0, and the 
clinical findings was analysed. PaO, and A-&O, served as 
objective variables, and the clinical factors as explanatory 
variables, in multiple regression analysis using the back- 
ward selection or F-value method. Dummy variables were 
used as discrete variables for the presence or absence or skin 
manifestations, normal or abnormal levels of blood ammo- 
nia, blood level of endotoxin, plasma level of glucagon, 
serum level of type IV collagen-7S, and the presence or 
absence of splenomegaly. Statistical significance of the 
findings was evaluated by the t-test and the F-test. A level of 
PO.05 was considered statistically significant. 
Results 
The mean level of PaO, was 78 + 11 (range: 43-95) torr. 
The mean level of A-aD0, was 19 i 13 (range: 2-60) 
torr. The four categories of PaO, with the number of 
patients in each were as follows: 43359.9 (n=2), 60-69.9 
(n=3), 70-79.9 (n=17), and 80-95 torr (n= 18). Mean values 
for % VC (100 * 15, range: 80.66129.3 %) and FEV, % 
(85 i 13, range: 70.2-127.6 %) were within ihe normal 
range in all patients. The mean level of I’,,lHt was 
0.46 * 0.25 (0.20-1.16) 1 s - r m ~ I; that of y-glltotal protein 
was 25 * 7 (12-43) %, and the mean ICG level was 17 i 17 
(3-65) %. 
Tables 1 and 2 show the relationship between the PaO,, 
the A-&O, and the clinical findings. PaO, was significantly 
correlated with the following nine variables; age, Ch-E 
level, y-glltotal protein level, ICG level, presence of skin 
manifestations, the blood level of ammonia, the blood level 
TABLE 1. Relationship between PaO, and clinical findings 
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Correlation coefficient 
@I 
Statistical 
analysis 
Age - 0.33 
%VC 0.12 
FEV,% 0.16 
t;,/body height (i/,,/Ht) 0.30 
AST (GOT) O-16 
ALT (GPT) o-22 
Cholinesterase (Ch-E) 0.43 
y-globulin/total protein - 0.39 
ICG excretion test (ICG level) - 0.69 
PCO.05 
NS 
NS 
NS 
NS 
NS 
P<O.Ol 
PCO.05 
P<O.O05 
PaO, (Torr) (Torr) 
Skin manifestations 
present:absent 
Blood ammonia 
abnormal:normal 
Blood endotoxin 
abnormal:normal 
Plasma glucagon 
abnormal:normal 
Serum type IV collagen-7S 
abnormal:normal 
Splenomegaly 
present:absent 
11 29 
67i 12 83 *I P<O.O05 
9 31 
69* 16 81 ztz8 P<O.Ol 
11 29 
665 12 83+7 P<O.O05 
10 30 
691k 15 8118 P<O,Ol 
27 13 
76% 12 83i7 NS 
22 18 
75* 13 821t7 PCO.05 
AST, asparate aminotransferase; ALT; alanine aminotransferase; ICG, indocyanine green; n, 
number of patients; NS, not significant; vital capacity (VC) is given as % predicted values. Values are 
means & S.D. 
of endotoxin, plasma level of glucagon, and the presence of 
splenomegaly. The A-&O, was significantly correlated 
with these variables, and also with the VJHt. 
Tables 3 and 4 show the explanatory variables with high 
partial correlation coefficients (PCC) following multiple 
regression analysis in which PaO, and A-&O, served as 
objective variables, with the clinical findings serving as 
explanatory variables. The clinical factors that were signifi- 
cantly correlated with PaO, and A-&O, in non-smokers 
with chronic liver disease who were positive for HCV 
antibody, were serum ICG level, blood level of endotoxin, 
and the presence of skin manifestations such as cutaneous 
spider nevi and palmar erythema. 
Figure 1 shows the relationship between the ICC level 
and A-&O,. The A-&O, was significantly correlated with 
the results of the ICG excretion test. 
Discussion 
The present study of the effect of clinical factors on blood 
gas tension was conducted in non-smokers, to avoid the 
influence of smoking on respiratory function (24). 
Hypoxaemia is present in patients with chronic liver 
disease of differing severity (1-16). It is variously considered 
to be caused by an alveolar ventilation-perfusion mismatch 
(11,14-16), by shunting due to intrapulmonary capillary 
dilatation (4,8,9,12) and by alveolar capillary diffusion 
limitation (10,13). Previously, the authors observed a 
70-year-old woman with right-to-left intrapulmonary 
shunting that was diagnosed on a pulmonary blood flow 
scintigram using ““Tc-MAA (macro-agg re g ated albumin) 
(5). It was thought that the hypoxaemia was due to 
dilatation of the intrapulmonary capillaries. Bethlot et al. 
observed the presence of precapillary dilatation in 13 
autopsied lungs of patients with liver cirrhosis (4). A gelatin 
suspension was injected into the lungs through the 
pulmonary artery. Six of the 13 cases showed vasodilatation 
and tortuous vessels on the pleura. Krowka and Cortese 
reviewed the hepatopulmonary syndrome and stated that 
the dilatation of the intrapulmonary vessels associated 
with liver disorders can cause profound hypoxaemia (2). 
Therefore, shunting due to capillary dilatation is regarded 
as the main mechanism (1,2,3). 
The ICG test is generally used for evaluating liver 
function. The peripheral clearance of ICG has been shown 
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TABLE 2. Relationship between A-aD0, and clinical findings 
Correlation coefficient 
CT) 
Statistical 
analysis 
Age 0.37 
%VC - 0.18 
FEV,% - 0.28 
PJbody height ( PJHt) - 0.32 
AST (GOT) - 0.16 
ALT (GPT) ~ 0.22 
Cholinesterase (Ch-E) - 0.45 
y-globulin/total protein 0.38 
ICG excretion test (ICG level) 0.78 
PCO.05 
NS 
NS 
P<O.OS 
NS 
NS 
PCO.01 
PiO.05 
P<O.O05 
A-aD0, (Torr) (Torr) 
Skin manifestations 
present:absent 
Blood ammonia 
abnormal:normal 
Blood endotoxin 
abnormal:normal 
Plasma glucagon 
abnormalknormal 
Serum type IV collagen-7S 
abnormal:normal 
Splenomegaly 
present:absent 
(n) 
(fl) 
(n) 
(n) 
(n) 
(n) 
11 
33 f 12 
9 
32 zt 15 
11 
31 Xt 15 
10 
31 f 15 
21 
21 f 14 
22 
22% 15 
29 
13&8 
31 
15k.9 
29 
14 f 9 
30 
14&9 
13 
14i9 
18 
14&8 
PCO.005 
PCO.005 
P<O.O05 
P<O.O05 
NS 
PCO.05 
A-aDO,, alveolar-arterial oxygen tension gradient; AST, asparate aminotransferase; ALT, alanine 
aminotransferase; ICG, indocyanine green; IZ, number of patients; NS, not significant; vital capacity 
(VC) is given as % predicted values. Values are means * S.D. 
TABLE 3. Multiple regression analysis for PaO, 
Explanatory variable PCC 
ICG excretion test - 0.615 
y-globulin/total protein 0.26 
Blood endotoxin* - 0.495 
Plasma glucagon” 0.34 
Skin manifestations? - 0.351 
F value 15.25 
R2 0.69 
PCC, partial correlation coefficient; ICG, indocyanine 
green; R2, coefficient of determination; *abnormal-l, 
normal-O (dummy variables); tpresent-1, absent-0 (dummy 
variables); JPcO.05; §P<O.Ol. 
to be a sensitive and reliable index of hepatic function 
(17,22). In the ICG excretion test, the blood level of ICG is 
correlated with the impairment of hepatic blood flow 
(17,22). The results of this test also parallel the severity of 
chronic liver disease (21). Namihisa et al. reported the 
following mean ICG levels in patients with various liver 
diseases: 11.2 & 6.3 in chronic inactive hepatitis (n=35), 
15.2 + 9.1 in chronic active hepatitis (n=55), and 
35.3 & 19.0 % in liver cirrhosis (n=54) (21). The present 
study showed the ICG level to be significantly correlated 
with the PaO, and A-aDO,, which indicates that reductions 
in hepatic blood flow and in hepatocellular function influ- 
enced the blood gases. Patients with chronic liver disease, 
especially those with cirrhosis, exhibit vasodilatation in the 
lung, skin, kidney and muscle (4). While the mechanism is 
unknown, it has been suggested that vasoactive substances 
such as endotoxin, glucagon, oestrogens and vasoactive 
intestinal peptide may fail to be inactivated due to a 
reduction in hepatic blood flow and in hepatocellular 
function. These substances may flow directly into the veins 
as a result of portal hypertension (5,6). 
Ohmoto et al. reported a close correlation between the 
blood level of endotoxin and that of ICG in patients with 
chronic liver disease (25). Numerous factors have been 
linked to endotoxaemia in patients with liver disease, 
including a decrease in reticula-endothelial function, a 
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TABLE 4. Multiple regression analysis for A-aD0, 
Explanatory variable PCC 
Age 
ICG excretion test 
y-globulin/total protein 
Blood endotoxin* 
Plasma glucagon” 
Skin manifestationsi- 
F value 
0.25 
0.595 
- 0.33 
0,35$ 
- 0.21 
0.49s 
17.65 
R2 0.76 
A-&O,, alveolar-arterial oxygen tension gradient; PCC, 
partial correlation coefficient; ICC, indocyanine green; R2, 
coefficient of determination; *abnormal-l, normal-0 
(dummy variables); tpresent-1, absent-0 (dummy vari- 
ables); *P<O.O5; §P<O.Ol. 
70, I 
60 1 l I 
0 _ -10 20 30 40 50 60 70 
ICG excretion test (“ro) 
FIG. 1. Relationship between alveolar-arterial oxygen 
tension gradient (A-&O,) and results of indocyanine 
green (ICG) excretion test. A-&O, was significantly 
correlated with results of the ICG excretion test (15-min 
retention rate, r=0.78, P<O.OOl). 
decrease in the antitoxic function of liver parenchymal cells, 
the presence of a well-developed hepatic collateral circu- 
lation, an increase in the peritoneal uptake of endotoxin, an 
increase in intestinal flora; an increase in the intestinal 
absorption of endotoxin, and a decrease in the endotoxin 
inactivation factor (25). Previously, the authors observed a 
cirrhotic patient with severe hypoxaemia whose blood was 
positive for endotoxin (5). Suffredini et al. observed changes 
in gas exchange and alveolar permeability in healthy 
humans administered with an intravenous injection of 
endotoxin (26). The present results obtained with multiple 
regression analysis also suggest that the presence of endo- 
toxin in the blood influences the blood gases of patients 
with chronic liver disease. 
The intrapulmonary vasodilatation that causes shunting 
may be caused by a mechanism similar to that which causes 
cutaneous spider nevi and palmar erythema (l-4,6). PaO, 
and A-&O, were each significantly correlated with the 
presence of such skin manifestations in the present study. 
Twelve of the 20 patients (65%) with cirrhosis and 
hypoxaemia in a previous study exhibited cutaneous spider 
nevi and palmar erythema (5). The earlier results, and those 
of the present study using multiple regression analysis, 
suggest a close relationship between hypoxaemia and such 
skin manifestations. 
In conclusion, this investigation of the relationship 
between blood gas tension at rest and clinical findings in 40 
non-smokers with chronic liver disease revealed the follow- 
ing factors to be significantly correlated with blood gas 
tension at rest: ICG level, blood endotoxin level and the 
presence of skin manifestations. These findings may suggest 
that a reduction in hepatic blood flow and in hepatocellular 
function, as indicated by results of the ICG test, interferes 
with the inactivation of vasoactive substances. The presence 
of portal hypertension may allow such substances to flow 
directly into the circulation. This condition could lead to 
skin manifestations such as cutaneous spider nevi and 
palmar erythema, as well as dilatation of the intrapulmon- 
ary capillaries and an increase in A-&O,. However, in the 
present study, the highest correlation was observed between 
the A-&O, and the ICG level, which supports the above 
suggestion that some substance(s) may enter the systemic 
circulation and dilate the intrapulmonary capillaries due to 
a reduction in hepatic blood flow and in hepatocellular 
function. Some patients with chronic liver disease who were 
administered a somatostatin analogue and those who 
received a liver transplant reportedly showed an improve- 
ment in hypoxaemia (27,28). Additional investigation 
is required to identify the substance(s) or conditions 
responsible for the hypoxaemia and the dilation of the 
intrapulmonary capillaries in patients with chronic liver 
disease. 
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